Professional Documents
Culture Documents
Population Men ages 65 to 75 years who Men ages 65 to 75 Women ages 65 to 75 Women who
have ever smoked* years who have years who have ever have never
never smoked* smoked smoked
Recommendation Screen once for abdominal Selectively screen No recommendation. Do not
aortic aneurysm (AAA) by for AAA. Grade: I statement screen for
ultrasonography. Grade: C AAA.
Grade: B Grade: D
Recommendation Screen for abnormal blood glucose. Offer or refer patients with
abnormal blood glucose to intensive behavioral counseling
interventions to promote a healthful diet and physical activity.
Grade: B
Recommendation No recommendation.
Grade: I (insufficient evidence)
Recommendation No recommendation
Recommendation No recommendation.
Grade: I statement
Risk Assessment The strongest risk factor for primary hypertension in children is elevated body mass index.
Other risk factors include low birthweight, male sex, ethnicity, and a family history of
hypertension.
BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic
Testing
Population Asymptomatic women who have not been diagnosed with BRCA-related cancer
Recommendation Screen women whose family history may Do not routinely recommend
be associated with an increased risk for genetic counseling or BRCA testing
potentially harmful BRCA mutations. to women whose family history is
Women with positive screening results not associated with an increased
should receive genetic counseling and, if risk for potentially harmful BRCA
indicated after counseling, BRCA testing. mutations.
Grade: B Grade: D
Risk Assessment Family history factors associated with increased likelihood of potentially harmful
BRCA mutations include breast cancer diagnosis before age 50 years, bilateral
breast cancer, family history of breast and ovarian cancer, presence of breast
cancer in ≥1 male family member, multiple cases of breast cancer in the family, ≥1
or more family member with 2 primary types of BRCA-related cancer, and
Ashkenazi Jewish ethnicity.
Recommendation Engage in shared, informed decision making Do not prescribe risk-reducing medications.
and offer to prescribe risk-reducing Grade: D
medications, if appropriate.
Grade: B
Recommendation Do not screen for asymptomatic carotid artery stenosis in the general adult
population.
Grade: D
Recommendation No recommendation.
Grade: I (insufficient evidence)
Recommendation Screen with Screen with Do not Do not Do not screen. Do not
cytology cytology screen. screen. Grade: D screen with
(Pap smear) every 3 years Grade: D Grade: D HPV
every 3 or co-testing testing
years. (cytology/HPV (alone or
Grade: A testing) every with
5 years. cytology).
Grade: A Grade: D
Recommendation No recommendation.
Grade: I statement
Chlamydia and Gonorrhea: Screening for Chlamydia and Gonorrhea:
Population Sexually active females Sexually active females Men
aged ≤24 y and older aged ≤24 y and older
No
women at increased risk women at increased risk
for infection: screen for for infection: screen for recommendation
chlamydia, grade: B gonorrhea, grade: B Grade:I
Recommendation No recommendation.
Grade: I statement
Colorectal Cancer: Screening
Population Adults aged 50 to 75 y Adults aged 76 to 85 y
Dental Caries in Children from Birth Through Age 5 Years: Screening of Birth
Through Age 5 Years: Clinical
Population Children age 5 years and younger
Recommendation Prescribe oral fluoride Apply fluoride varnish Routine oral screening
supplementation starting at to the primary teeth of examinations: No
age 6 months for children all infants and children recommendation.
whose water supply is starting at the age of Grade: I statement
deficient in fluoride. primary tooth
Grade: B eruption.
Grade: B
(<0.6PPM)
Depression in Adults: Screening
Population Adults aged ≥18 y
Recommendation No recommendation
Grade: I (Insufficient Evidence)
Drug Use, Illicit: Primary Care Interventions for Children and Adolescents
Population Children and adolescents younger than age 18 years who have not
already been diagnosed with a substance use disorder
Recommendation No recommendation.
Grade: I statement
Falls Prevention in Older Adults: Counseling and Preventive Medication
Population Community-dwelling adults aged 65 Community-dwelling adults aged 65 years
years and older who are at increased and older
risk for falls
Recommendation Take a daily supplement containing 0.4 to 0.8 mg (400 to 800 µg) of folic acid.
Grade: A
Population Asymptomatic adolescents and adults, including those who are pregnant
Recommendation Do not routinely screen for genital herpes simplex virus (HSV) infection.
Grade: D
Recommendation No recommendation.
Grade: I statement
Recommendation No recommendation.
Grade: I (insufficient evidence)
Note: This statement does not apply to specific disorders for which the USPSTF already
recommends screening (i.e., screening for cervical cancer with a Pap smear, screening for
gonorrhea and chlamydia).
Recommendation No recommendation.
Grade: I (Insufficient Evidence)
Recommendation No recommendation.
Grade: I statement (insufficient evidence)
Recommendation No recommendation.
Grade: I (insufficient evidence)
Recommendation Screen annually for lung cancer with low-dose computed tomography.
Discontinue screening when the patient has not smoked for 15 years.
Grade: B
Obesity in Adults: Screening and Management
U.S. Preventive Services Task Force Recommendation
Population Adults aged 18 years or older
Recommendation Screen for obesity. Patients with a body mass index (BMI) of 30
kg/m2 or higher should be offered or referred to intensive,
multicomponent behavioral interventions. Grade: B
Recommendation Screen for obesity; offer or refer children and adolescents with obesity to
comprehensive, intensive behavioral interventions to promote
improvements in weight status.
Grade: B
Recommendation No recommendation.
Grade: I (insufficient evidence)
Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive
Medicationl
Grade: A
Recommendation No recommendation.
Grade: I Statement
Osteoporosis: Screening
Population Women age ≥65 Women age <65 years Men without previous
years without whose 10-year fracture known fractures or
previous known risk is equal to or secondary causes of
fractures or greater than that of a osteoporosis
secondary causes of 65-year-old white
osteoporosis woman without
additional risk factors
Grade: B Grade: I
(insufficient evidence)
Ovarian Cancer: Screening
Population Asymptomatic women without known genetic mutations that increase risk
for ovarian cancer
Grade: D
Recommendation No recommendation.
Grade: I statement
Preeclampsia: Screening
Population Pregnant women without a known diagnosis of preeclampsia or hypertension
Recommendation Screen for preeclampsia with blood pressure measurements throughout pregnancy.
Grade: B
Recommendation Do not use prostate-specific antigen (PSA)–based screening for prostate cancer.
Grade: D
Recommendation No recommendation
Grade: I (insufficient evidence)
Recommendation No recommendation.
Grade: I statement (insufficient evidence)
Population Adults aged 40–75 y with Adults aged 40–75 y with Adults 76 y and older
no history of CVD, ≥1 CVD no history of CVD, ≥1 CVD with no
risk factors, and calculated risk factors, and calculated history of CVD
10-y CVD event risk of 10-y CVD event risk of
≥10% 7.5%–10%
Population Adolescents, adults, and older adults in the general U.S. population who do not
have an identified psychiatric disorder
Grade: A
Grade: D
Thyroid Cancer: Screening
Recommendation No recommendation.
Grade: I statement (insufficient evidence)
Population Nonpregnant Pregnant women Pregnant women All adults age ≥18 y
adults age ≥18 y age ≥18 y age ≥18 y
Recommendation No recommendation.
Grade: I statement (insufficient evidence)
This recommendation does not apply to children, women who are pregnant or may
become pregnant, or persons who are chronically ill or hospitalized or have a known
nutritional deficiency.
Recommendation Multivitamins: Single- or paired-nutrient β-carotene or vitamin
No recommendation. supplements: E:
Grade: I statement No recommendation. Do not recommend.
Grade: I statement Grade: D